They transfected glioblastoma cells with mutant IκBα (IκBαM), an inhibitory protein that sequesters and blocks NF-κB. In this model, they observed a profound reduction in expression of CXCL8 that attenuated tumor associated angiogenesis. This evidence concerns the gene NFKB1 and neoplasm.